As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Biopharmaceutical Market: By Indication: Autoimmune Diseases, Oncology, Metabolic Disorders; By Class: Recombinant Proteins, Monoclonal Antibodies, Purified Proteins; Regional Analysis; Historical Market and Forecast (2015-2025); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Biopharmaceutical Market Outlook

The global biopharmaceutical market reached a value of about USD 215.4 billion in 2019. The market is further expected to grow at a CAGR of about 7.5% in the forecast period of 2020-2025 to reach a value of approximately USD 332.4 billion by 2025. 

The biopharmaceutical market is overwhelmingly dominated by the United States, accounting for almost half of all global revenue. The other major markets are Germany, Japan, France, Italy, Spain, the United Kingdom, and Canada. Due to the rising disposable incomes and greater access to health benefits, the biopharmaceutical market is also likely to develop and deliver tremendous opportunities and growth prospects in various emerging markets over the next few years. The rising geriatric population, rising product awareness, and the growing spending on healthcare are the few factors boosting the growth of this sector. Therefore, the clearance for newer biopharmaceutical products and continuous R&D in this sector are expected to influence the biopharmaceutical market positively.

Based on indication, autoimmune diseases lead the industry because biopharmaceuticals are more successful in treating these diseases as compared to small molecule drugs. Autoimmune diseases are followed by oncology and metabolic disorders. On the other hand, recombinant proteins account for the majority of the total share, representing the leading segment of the class. Recombinant proteins are followed by monoclonal antibodies as well as purified proteins. Monoclonal antibodies are likely to be the fastest-growing class on account of high unmet medical needs in arthritis, cancer, RSV, and psoriasis.

 

Properties and Applications

Biopharmaceuticals are large molecules and complex drugs primarily derived from proteins and nucleic acids extracted from living organisms. They are typically administered by intravenous, subcutaneous or intramuscular injections and are more effective than traditional small molecule drugs. Biopharmaceuticals have improved the treatment of a variety of illnesses, like diabetes, cardiovascular disorders, and others, because they can be adapted to medical needs.

On the basis of indication, the industry is divided into:

  • Autoimmune Diseases
  • Oncology
  • Metabolic Disorders
  • Others

Based on class, the industry can be divided into the following:

  • Recombinant Proteins
  • Monoclonal Antibodies
  • Purified Proteins

The regional markets for biopharmaceutical include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Market Analysis

Biopharmaceuticals are functionally similar to human products, which enhance the ability of such medications to cure diseases rather than merely treat symptoms. This has generated a growing biopharmaceutical market around the globe. As compared to traditional medications, owing to their precision, biopharmaceuticals have fewer side effects. In addition, these medications may be adjusted on the basis of the specific requirements of patients who have raised their demand, thus, enhancing the growth of the global biopharmaceutical market. An increase in the geriatric population, along with an increase in health care expenditure due to inflation in per capita income, is expected to drive the growth of the biopharmaceutical market.

 

Competitive Landscape 

The report gives a detailed analysis of the following key players in the global biopharmaceutical market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Amgen Inc
  • Genentech, Inc
  • EMD Serono, Inc.
  • Biogen
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Biopharmaceutical Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Biopharmaceutical Historical Market (2015-2019) 
    8.3    Global Biopharmaceutical Market Forecast (2020-2025)
    8.4    Global Biopharmaceutical Market by Indication
        8.4.1    Autoimmune Diseases 
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2015-2019)
            8.4.1.3    Forecast Trend (2020-2025)
        8.4.2    Oncology 
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2015-2019)
            8.4.2.3    Forecast Trend (2020-2025)
        8.4.3    Metabolic Disorders
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2015-2019)
            8.4.3.3    Forecast Trend (2020-2025)
        8.4.4    Others
    8.5    Global Biopharmaceutical Market by Class
        8.5.1    Recombinant Proteins
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2015-2019)
            8.5.1.3    Forecast Trend (2020-2025)
        8.5.2    Monoclonal Antibodies 
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2015-2019)
            8.5.2.3    Forecast Trend (2020-2025)
        8.5.3    Purified Proteins
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2015-2019)
            8.5.3.3    Forecast Trend (2020-2025)
    8.6    Global Biopharmaceutical Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2015-2019)
        9.1.2    Forecast Trend (2020-2025)
        9.1.3    Breakup by Class
            9.1.3.1    Recombinant Proteins  
            9.1.3.2    Monoclonal Antibodies 
            9.1.3.3    Purified Proteins
        9.1.4    Breakup by Country
            9.1.4.1    United States of America 
            9.1.4.2    Canada
        9.1.5    Key Players
    9.2    Europe
        9.2.1    Historical Trend (2015-2019)
        9.2.2    Forecast Trend (2020-2025)
        9.2.3    Breakup by Class
            9.2.3.1    Recombinant Proteins  
            9.2.3.2    Monoclonal Antibodies 
            9.2.3.3    Purified Proteins
        9.2.4    Breakup by Country
            9.2.4.1    United Kingdom
            9.2.4.2    Germany
            9.2.4.3    France
            9.2.4.4    Italy
            9.2.4.5    Spain
            9.2.4.6    Spain
            9.2.4.7    Russia
            9.2.4.8    Turkey
            9.2.4.9    Others
        9.2.5    Key Players
    9.3    Asia Pacific
        9.3.1    Historical Trend (2015-2019)
        9.3.2    Forecast Trend (2020-2025)
        9.3.3    Breakup by Class
            9.3.3.1    Recombinant Proteins  
            9.3.3.2    Monoclonal Antibodies 
            9.3.3.3    Purified Proteins
        9.3.4    Breakup by Country
            9.3.4.1    China
            9.3.4.2    Japan
            9.3.4.3    India
            9.3.4.4    ASEAN
            9.3.4.5    Australia
            9.3.4.6    Others
        9.3.5    Key Players
    9.4    Latin America
        9.4.1    Historical Trend (2015-2019)
        9.4.2    Forecast Trend (2020-2025)
        9.4.3    Breakup by Class
            9.4.3.1    Recombinant Proteins  
            9.4.3.2    Monoclonal Antibodies 
            9.4.3.3    Purified Proteins
        9.4.4    Breakup by Country
            9.4.4.1    Brazil
            9.4.4.2    Argentina
            9.4.4.3    Mexico
            9.4.4.4    Others
        9.4.5    Key Players
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2015-2019)
        9.5.2    Forecast Trend (2020-2025)
        9.5.3    Breakup by Class
            9.5.3.1    Recombinant Proteins  
            9.5.3.2    Monoclonal Antibodies 
            9.5.3.3    Purified Proteins
        9.5.4    Breakup by Country
            9.5.4.1    Saudi Arabia
            9.5.4.2    United Arab Emirates
            9.5.4.3    Nigeria
            9.5.4.4    South Africa
            9.5.4.5    Others
        9.5.5    Key Players
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyers Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players’ Market Share
    12.3    Company Profile
        12.3.1    Amgen Inc
            12.3.1.1    Company Overview
            12.3.1.2    Product Portfolio
            12.3.1.3    Demographic Reach and Achievements
            12.3.1.4    Certifications
        12.3.2    Genentech, Inc
            12.3.2.1    Company Overview
            12.3.2.2    Product Portfolio
            12.3.2.3    Demographic Reach and Achievements
            12.3.2.4    Certifications
        12.3.3    EMD Serono, Inc.
            12.3.3.1    Company Overview
            12.3.3.2    Product Portfolio
            12.3.3.3    Demographic Reach and Achievements
            12.3.3.4    Certifications
        12.3.4    Biogen
            12.3.4.1    Company Overview
            12.3.4.2    Product Portfolio
            12.3.4.3    Demographic Reach and Achievements
            12.3.4.4    Certifications
        12.3.5    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Biopharmaceutical Market: Key Industry Highlights, 2015 and 2025
2.    Global Biopharmaceutical Historical Market: Breakup by Indication (USD Billion), 2015-2019
3.    Global Biopharmaceutical Market Forecast: Breakup by Indication (USD Billion), 2020-2025
4.    Global Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
5.    Global Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
6.    Global Biopharmaceutical Historical Market: Breakup by Region (USD Billion), 2015-2019
7.    Global Biopharmaceutical Market Forecast: Breakup by Region (USD Billion), 2020-2025
8.    North America Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
9.    North America Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
10.    North America Biopharmaceutical Historical Market: Breakup by Country (USD Billion), 2015-2019
11.    North America Biopharmaceutical Market Forecast: Breakup by Country (USD Billion), 2020-2025
12.    Europe Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
13.    Europe Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
14.    Europe Biopharmaceutical Historical Market: Breakup by Country (USD Billion), 2015-2019
15.    Europe Biopharmaceutical Market Forecast: Breakup by Country (USD Billion), 2020-2025
16.    Asia Pacific Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
17.    Asia Pacific Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
18.    Asia Pacific Biopharmaceutical Historical Market: Breakup by Country (USD Billion), 2015-2019
19.    Asia Pacific Biopharmaceutical Market Forecast: Breakup by Country (USD Billion), 2020-2025
20.    Latin America Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
21.    Latin America Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
22.    Latin America Biopharmaceutical Historical Market: Breakup by Country (USD Billion), 2015-2019
23.    Latin America Biopharmaceutical Market Forecast: Breakup by Country (USD Billion), 2020-2025
24.    Middle East and Africa Biopharmaceutical Historical Market: Breakup by Class (USD Billion), 2015-2019
25.    Middle East and Africa Biopharmaceutical Market Forecast: Breakup by Class (USD Billion), 2020-2025
26.    Middle East and Africa Biopharmaceutical Historical Market: Breakup by Country (USD Billion), 2015-2019
27.    Middle East and Africa Biopharmaceutical Market Forecast: Breakup by Country (USD Billion), 2020-2025
28.    Global Biopharmaceutical Market Structure

Key Questions Answered in the Report

In 2019, the global biopharmaceutical market attained a value of nearly USD 215.4 billion. 

The market is projected to grow at a CAGR of 7.5% between 2020 and 2025.

The market is estimated to witness a healthy growth in the forecast period of 2020-2025 to reach about USD 332.4 billion by 2025. 

The major drivers of the industry, such as rising disposable incomes, greater access to health benefits, growth prospects in various emerging markets, rising geriatric population, rising awareness, and growing spending on health care, are expected to aid the market growth.

The key market trend guiding the growth of the biopharmaceuticals market include the newer biopharmaceutical products and continuous R&D in this sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. 

The major indication sectors of biopharmaceutical in the industry are autoimmune diseases, oncology, metabolic disorders, and others.

The major classes of biopharmaceutical are recombinant proteins, monoclonal antibodies, and purified proteins. 

The major players in the industry are Amgen Inc, Genentech, Inc, EMD Serono, Inc., and Biogen, among others.

Analyst Review

The global biopharmaceutical market attained a value of USD 215.4 billion in 2019, driven by the rising geriatric population. Aided by the creation of newer and advanced biopharmaceutical products, the market is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 7.5%. The biopharmaceutical market is projected to reach USD 332.4 billion by 2025. 

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its indication sectors, the biopharmaceutical market can be segmented into autoimmune diseases, oncology, metabolic disorders, and others. On the basis of class, the industry is divided into recombinant proteins, monoclonal antibodies, and purified proteins. The major regional markets for biopharmaceutical are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc, Genentech, Inc, EMD Serono, Inc., Biogen, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1099
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Biosimilar Market Report and Forecast 2020-2025


Europe Biosimilar Market Report and Forecast 2020-2025


NEWSLETTER